Does SUNITINIB MALATE Cause Neoplasm progression? 1,920 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,920 reports of Neoplasm progression have been filed in association with SUNITINIB MALATE (Sunitinib malate). This represents 8.9% of all adverse event reports for SUNITINIB MALATE.
1,920
Reports of Neoplasm progression with SUNITINIB MALATE
8.9%
of all SUNITINIB MALATE reports
545
Deaths
558
Hospitalizations
How Dangerous Is Neoplasm progression From SUNITINIB MALATE?
Of the 1,920 reports, 545 (28.4%) resulted in death, 558 (29.1%) required hospitalization, and 46 (2.4%) were considered life-threatening.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SUNITINIB MALATE. However, 1,920 reports have been filed with the FAERS database.
What Other Side Effects Does SUNITINIB MALATE Cause?
Death (4,385)
Diarrhoea (3,044)
Fatigue (2,865)
Nausea (2,032)
Disease progression (1,745)
Decreased appetite (1,676)
Asthenia (1,651)
Vomiting (1,331)
Dysgeusia (1,226)
Malaise (1,202)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
GEMCITABINE (960)
Which SUNITINIB MALATE Alternatives Have Lower Neoplasm progression Risk?
SUNITINIB MALATE vs SUTENT
SUNITINIB MALATE vs SUTIMLIMAB-JOME
SUNITINIB MALATE vs SUVOREXANT
SUNITINIB MALATE vs SUZETRIGINE
SUNITINIB MALATE vs SYMBICORT